(Q43764184)

26 November 2017

Velnacrine thiaanalogues as potential agents for treating Alzheimer's disease (English)

1 reference

26 November 2017

0 references

1

1 reference

26 November 2017

2

1 reference

26 November 2017

3

1 reference

26 November 2017

Filipponi E

4

1 reference

26 November 2017

Lamperti MG

series ordinal

5

1 reference

26 November 2017

Fravolini A

series ordinal

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

26 November 2017

8

1 reference

Bioorganic & Medicinal Chemistry

inferred from page(s)

published in

1 reference

26 November 2017

9

1 reference

26 November 2017

11

1 reference

26 November 2017

2921-2928

1 reference

Current approaches to the treatment of Alzheimer's disease

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

The cholinergic hypothesis--ten years on.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

Cholinergic strategies for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

Cholinergic strategies in the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

The therapeutic potential of tacrine.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

Novel piperidine derivatives. Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[2-(N-benzoylamino)ethyl]piperidine derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

The simulated binding of (+/-)-2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]meth yl] -1H-inden-1-one hydrochloride (E2020) and related inhibitors to free and acylated acetylcholinesterases and corresponding structure-activity analyse

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

Review of the acetylcholinesterase inhibitor galanthamine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

Three-dimensional structures of acetylcholinesterase and of its complexes with anticholinesterase agents

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

N-(aminophenyl)oxamic acids and esters as potent, orally active antiallergy agents

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

A new and rapid colorimetric determination of acetylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

Atomic Structure of Acetylcholinesterase from Torpedo californica : A Prototypic Acetylcholine-Binding Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

Binding of tacrine and 6-chlorotacrine by acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

Naltrexone-reversible effects of flunitrazepam on locomotor activity and passive avoidance behaviour in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900171-7

7 January 2021

10.1016/S0968-0896(01)00171-7

Identifiers

DOI

1 reference

26 November 2017

1 reference